Archives202520242023202220212020201920182017201620152014201320122011 December 24, 2021TR1 – Lanstead – Major Holding in Shares Read More December 20, 2021Subscriptions and Placing to raise £3.55 million; Sharing Agreement; to fund Investment in R&D pipeline • Company’s Partner Alora and two longstanding investors including Lanstead to participate at an Issue price of 11p – 80% premium to current share price Read More November 29, 2021Collaboration with Imperial College London Read More November 18, 2021CORPORATE UPDATE – The Evolution of ImmuPharma Read More October 01, 2021EURONEXT DELISTING – Date: 18 October 2021 Read More September 30, 2021Prof. Sylviane Muller awarded prestigious Legion d’honneur.’ Read More September 29, 2021Corporate Update Read More September 29, 2021INTERIM RESULTS ANNOUNCEMENT for the six months ended 30 June 2021 Read More August 24, 2021Director & PDMR Share Purchases Read More August 17, 2021Lanstead Capital TR1 Read More August 12, 2021FDA approves the Lupzuor™ PK study Read More July 30, 2021BOARD CHANGES Read More 12
December 20, 2021Subscriptions and Placing to raise £3.55 million; Sharing Agreement; to fund Investment in R&D pipeline • Company’s Partner Alora and two longstanding investors including Lanstead to participate at an Issue price of 11p – 80% premium to current share price Read More
